相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Combined inhibition of RAC1 and Bcl-2/Bcl-xL synergistically induces glioblastoma cell death through down-regulation of the Usp9X/Mcl-1 axis
Michal Hlavac et al.
CELLULAR ONCOLOGY (2019)
Glycolytic inhibitor 2-Deoxy-D-Glucose activates migration and invasion in glioblastoma cells through modulation of the miR-7-5p/TFF3 signaling pathway
Akanchha Shukla et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
Intratumoral activity of ONC201 in adult recurrent glioblastoma patients
Isabel Arrillaga et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Metabolic Reprogramming by Dual AKT/ERK Inhibition through Imipridones Elicits Unique Vulnerabilities in Glioblastoma
Chiaki T. Ishida et al.
CLINICAL CANCER RESEARCH (2018)
Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma A Randomized Clinical Trial
Roger Stupp et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Induction of synthetic lethality in IDH1-mutated gliomas through inhibition of Bcl-xL
Georg Karpel-Massler et al.
NATURE COMMUNICATIONS (2017)
A phase 2 study of the first imipridone ONC201, a selective DRD2 antagonist for oncology, administered every three weeks in recurrent glioblastoma
Isabel Arrillaga-Romany et al.
ONCOTARGET (2017)
Cancer stem cell-related gene expression as a potential biomarker of response for first-in-class imipridone ONC201 in solid tumors
Varun V. Prabhu et al.
PLOS ONE (2017)
First-in-Human Clinical Trial of Oral ONC201 in Patients with Refractory Solid Tumors
Mark N. Stein et al.
CLINICAL CANCER RESEARCH (2017)
A paired comparison between glioblastoma stem cells and differentiated cells
Matthias Schneider et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
The Emerging Hallmarks of Cancer Metabolism
Natalya N. Pavlova et al.
CELL METABOLISM (2016)
A Synthetic Cell-Penetrating Dominant-Negative ATF5 Peptide Exerts Anticancer Activity against a Broad Spectrum of Treatment-Resistant Cancers
Georg Karpel-Massler et al.
CLINICAL CANCER RESEARCH (2016)
Small-Molecule ONC201/TIC10 Targets Chemotherapy-Resistant Colorectal Cancer Stem-like Cells in an Akt/Foxo3a/TRAIL-Dependent Manner
Varun V. Prabhu et al.
CANCER RESEARCH (2015)
Olanzapine inhibits proliferation, migration and anchorage-independent growth in human glioblastoma cell lines and enhances temozolomide's antiproliferative effect
Georg Karpel-Massler et al.
JOURNAL OF NEURO-ONCOLOGY (2015)
A Potential Role for the Inhibition of PI3K Signaling in Glioblastoma Therapy
Stephanie Stroebele et al.
PLOS ONE (2015)
Artesunate Enhances the Antiproliferative Effect of Temozolomide on U87MG and A172 Glioblastoma Cell Lines
Georg Karpel-Massler et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2014)
PARP Inhibition Restores Extrinsic Apoptotic Sensitivity in Glioblastoma
Georg Karpel-Massler et al.
PLOS ONE (2014)
A phase I dose-escalation trial of 2-deoxy-D-glucose alone or combined with docetaxel in patients with advanced solid tumors
Luis E. Raez et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2013)
Differential sensitivities of glioblastoma cell lines towards metabolic and signaling pathway inhibitions
Colin R. Kennedy et al.
CANCER LETTERS (2013)
Combined Inhibition of HER1/EGFR and RAC1 Results in a Synergistic Antiproliferative Effect on Established and Primary Cultured Human Glioblastoma Cells
Georg Karpel-Massler et al.
MOLECULAR CANCER THERAPEUTICS (2013)
Dual Inactivation of Akt and ERK by TIC10 Signals Foxo3a Nuclear Translocation, TRAIL Gene Induction, and Potent Antitumor Effects
Joshua E. Allen et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Passenger deletions generate therapeutic vulnerabilities in cancer
Florian L. Muller et al.
NATURE (2012)
Cancer Invasion and the Microenvironment: Plasticity and Reciprocity
Peter Friedl et al.
CELL (2011)
Phosphatidylinostol 3-kinase inhibition broadly sensitizes glioblastoma cells to death receptor- and drug-induced apoptosis
Daniela Opel et al.
CANCER RESEARCH (2008)
Optimizing cancer radiotherapy with 2-deoxy-D-glucose - Dose escalation studies in patients with glioblastoma multiforme
DH Singh et al.
STRAHLENTHERAPIE UND ONKOLOGIE (2005)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
分享论文
